Casting Vote at CMCC. If a dispute at the CMCC is not resolved pursuant to Section 2.4 above, then (i) in the case of any disputes relating to the Intrexon Materials, the manufacture of an Oragenics Product active pharmaceutical ingredient, or the manufacturing of other components of Oragenics Products contracted for or manufactured by Intrexon, the Executive Officer of Intrexon shall have the authority to finally resolve such dispute; and (ii) in the case of any other disputes, the Executive Officer of Oragenics shall have the authority to finally resolve such dispute.
Appears in 5 contracts
Samples: Exclusive Channel Collaboration Agreement (Oragenics Inc), Exclusive Channel Collaboration Agreement (Oragenics Inc), Confidential Treatment (Oragenics Inc)
Casting Vote at CMCC. If a dispute at the CMCC is not resolved pursuant to Section 2.4 above, then (i) in the case of any disputes relating to the Intrexon Materials, the manufacture of an Oragenics a ZIOPHARM Product active pharmaceutical ingredient, or the manufacturing of other components of Oragenics ZIOPHARM Products contracted for or manufactured by Intrexon, the Executive Officer of Intrexon shall have the authority to finally resolve such dispute; and (ii) in the case of any other disputes, the Executive Officer of Oragenics ZIOPHARM shall have the authority to finally resolve such dispute.
Appears in 5 contracts
Samples: Exclusive Channel Partner Agreement (Intrexon Corp), Exclusive Channel Partner Agreement (Ziopharm Oncology Inc), Exclusive Channel Partner Agreement (Intrexon Corp)
Casting Vote at CMCC. If a dispute at the CMCC is not resolved pursuant to Section 2.4 above, then (i) in the case of any disputes relating to the Intrexon Materials, the manufacture of an Oragenics Adeona Product active pharmaceutical ingredient, or the manufacturing of other components of Oragenics Adeona Products contracted for or manufactured by Intrexon, the Executive Officer of Intrexon shall have the authority to finally resolve such dispute; and (ii) in the case of any other disputes, the Executive Officer of Oragenics Adeona shall have the authority to finally resolve such dispute.
Appears in 2 contracts
Samples: Exclusive Channel Collaboration Agreement (Adeona Pharmaceuticals, Inc.), Collaboration Agreement (Adeona Pharmaceuticals, Inc.)
Casting Vote at CMCC. If a dispute at the CMCC is not resolved pursuant to Section 2.4 above, then (i) in the case of any disputes relating to the Intrexon Materials or controls regarding the dissemination of Intrexon IP or Intrexon Materials, the manufacture of an Oragenics Product active pharmaceutical ingredient, or the manufacturing of other components of Oragenics Products contracted for or manufactured by Intrexon, the Executive Officer of Intrexon shall have the authority to finally resolve such dispute; and (ii) in the case of any other disputes, including the manufacture of a Synthetic Product active pharmaceutical ingredient, the Executive Officer of Oragenics Synthetic shall have the authority to finally resolve such dispute.
Appears in 1 contract
Samples: Collaboration Agreement (Synthetic Biologics, Inc.)
Casting Vote at CMCC. If a dispute at the CMCC is not resolved pursuant to Section 2.4 above, then (i) in the case of any disputes relating to the Intrexon EGI Materials, the manufacture of an Oragenics Product active pharmaceutical ingredient, or the manufacturing of other components of Oragenics Products contracted for or manufactured by IntrexonEGI, the Executive Officer of Intrexon EGI shall have the authority to finally resolve such dispute; and (ii) in the case of any other disputes, the Executive Officer of Oragenics shall have the authority to finally resolve such dispute.
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Oragenics Inc)